Sleep Aids - Worldwide

  • Worldwide
  • Revenue in the Sleep Aids market amounts to €4.79bn in 2024. The market is expected to grow annually by 4.95% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (€1,922m in 2024).
  • In relation to total population figures, per person revenues of €0.62 are generated in 2024.

Key regions: Thailand, Indonesia, United States, Europe, Philippines

Comparaison de régions

Analyst Opinion

Sleep aids are becoming increasingly popular worldwide as people are recognizing the importance of a good night's sleep for their overall health and well-being. With busy and stressful lifestyles, many individuals are experiencing difficulty falling asleep or staying asleep throughout the night. As a result, the sleep aids market has seen significant growth in recent years.

Customer preferences:
Customers are increasingly seeking natural and non-habit forming sleep aids. There is a growing demand for products that promote relaxation and help individuals fall asleep naturally. Herbal supplements, such as melatonin and valerian root, have gained popularity as they are perceived as safe and effective alternatives to prescription sleep aids. Additionally, consumers are looking for products that address specific sleep issues, such as insomnia or sleep apnea.

Trends in the market:
The sleep aids market is witnessing a shift towards innovative and technologically advanced products. Sleep tracking devices, such as smartwatches and fitness bands, are gaining traction as they provide individuals with insights into their sleep patterns and offer personalized recommendations for improving sleep quality. These devices are becoming increasingly sophisticated, with features such as heart rate monitoring and personalized sleep coaching.

Local special circumstances:
In developed countries, where stress and anxiety levels are high, the demand for sleep aids is particularly strong. Long working hours, demanding lifestyles, and the prevalence of technology contribute to sleep disturbances, leading individuals to seek sleep aids for relief. In contrast, in developing countries, where access to healthcare and awareness about sleep disorders may be limited, the market for sleep aids is still emerging.

Underlying macroeconomic factors:
The increasing prevalence of sleep disorders, such as insomnia and sleep apnea, is a key driver of the sleep aids market. Factors such as aging populations, rising obesity rates, and the growing awareness of the importance of sleep are contributing to the higher incidence of sleep disorders. Additionally, the increasing disposable income in emerging economies is enabling more individuals to afford sleep aids and invest in their sleep health. In conclusion, the sleep aids market is witnessing significant growth worldwide as individuals recognize the importance of a good night's sleep. Customer preferences are shifting towards natural and non-habit forming sleep aids, while technological advancements are driving innovation in the market. Local special circumstances, such as high stress levels in developed countries, contribute to the demand for sleep aids. Underlying macroeconomic factors, such as the increasing prevalence of sleep disorders and rising disposable income, are also fueling the growth of the market.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Vue d’ensemble

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter


Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Temitope Ifekoya
Temitope Ifekoya
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)